These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 1929451

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M, Huitema AD, Meenhorst PL, Schellens JH, Beijnen JH.
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies.
    Zia-Amirhosseini P, Hurd DD, Salfi M, Cheah TC, Aycock J, Cesano A.
    Pharmacotherapy; 2007 Oct; 27(10):1353-60. PubMed ID: 17896890
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
    Kearns CM, Blakley RL, Santana VM, Crom WR.
    Cancer Res; 1994 Mar 01; 54(5):1235-9. PubMed ID: 7906999
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of gender, age, and race on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients.
    Kaul S, Srinivas NR, Mummaneni V, Igwemezie LN, Barbhaiya RH.
    Semin Oncol; 1996 Dec 01; 23(6 Suppl 13):23-9. PubMed ID: 8996572
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Unchanged pharmacokinetics of etoposide given by intra-arterial hepatic infusion as compared with i.v. infusion.
    van Tellingen O, Kuck MT, Vlasveld LT, Rodenhuis S, Nooijen WJ, Beijnen JH.
    Cancer Chemother Pharmacol; 1996 Dec 01; 38(4):387-90. PubMed ID: 8674164
    [Abstract] [Full Text] [Related]

  • 32. A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients.
    Tranchand B, Amsellem C, Chatelut E, Freyer G, Iliadis A, Ligneau B, Trillet-Lenoir V, Canal P, Lochon I, Ardiet CJ.
    Cancer Chemother Pharmacol; 1999 Dec 01; 43(4):316-22. PubMed ID: 10071983
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Removal of doripenem during hemodialysis and the optimum dosing regimen for patients undergoing hemodialysis.
    Tanoue K, Nishi K, Kadowaki D, Hirata S.
    Ther Apher Dial; 2011 Jun 01; 15(3):327-33. PubMed ID: 21624085
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of etoposide with intravenous drug administration in children and adolescents.
    Kato Y, Nishimura S, Sakura N, Ueda K.
    Pediatr Int; 2003 Feb 01; 45(1):74-9. PubMed ID: 12654074
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Disposition of total and unbound etoposide following high-dose therapy.
    Schwinghammer TL, Fleming RA, Rosenfeld CS, Przepiorka D, Shadduck RK, Bloom EJ, Stewart CF.
    Cancer Chemother Pharmacol; 1993 Feb 01; 32(4):273-8. PubMed ID: 8324869
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of high-dose etoposide.
    Newman EM, Doroshow JH, Forman SJ, Blume KG.
    Clin Pharmacol Ther; 1988 May 01; 43(5):561-4. PubMed ID: 3284691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.